Total Payments
$5,908
2024 Payments
$639.77
Companies
38
Transactions
306
Medicare Patients
4,044
Medicare Billing
$460,459
Payment Breakdown by Category
Food & Beverage$5,908 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,908 | 306 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,770 | 96 | $0 (2024) |
| Janssen Biotech, Inc. | $555.52 | 30 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $517.87 | 27 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $459.40 | 25 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $301.41 | 11 | $0 (2024) |
| Allergan, Inc. | $247.72 | 29 | $0 (2020) |
| Lumendi LLC | $231.48 | 3 | $0 (2020) |
| PFIZER INC. | $225.66 | 10 | $0 (2023) |
| Braintree Laboratories, Inc. | $212.56 | 9 | $0 (2023) |
| Medtronic, Inc. | $144.45 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $639.77 | 30 | ABBVIE INC. ($374.75) |
| 2023 | $1,117 | 53 | ABBVIE INC. ($349.20) |
| 2022 | $1,025 | 50 | ABBVIE INC. ($273.46) |
| 2021 | $602.85 | 29 | AbbVie Inc. ($219.80) |
| 2020 | $332.37 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($112.23) |
| 2019 | $743.96 | 37 | AbbVie, Inc. ($149.71) |
| 2018 | $805.73 | 37 | Lumendi LLC ($195.48) |
| 2017 | $642.23 | 53 | Allergan Inc. ($169.78) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Immunology | ||||||
| 06/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: INFLIXIMAB | ||||||
| 05/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.20 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,054 | 1,161 | $559,404 | $121,436 |
| 2022 | 15 | 1,058 | 1,172 | $559,707 | $119,839 |
| 2021 | 14 | 1,045 | 1,162 | $548,601 | $119,804 |
| 2020 | 13 | 887 | 968 | $440,463 | $99,380 |
Total Patients
4,044
Total Services
4,463
Medicare Billing
$460,459
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 116 | 118 | $99,524 | $26,625 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 334 | $101,785 | $22,536 | 22.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 125 | 125 | $83,000 | $12,073 | 14.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 157 | 163 | $74,817 | $11,790 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 102 | $44,166 | $10,562 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $43,758 | $9,112 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $38,148 | $8,758 | 23.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $23,111 | $7,367 | 31.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $12,280 | $3,938 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $14,996 | $3,386 | 22.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $12,873 | $3,253 | 25.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $8,526 | $1,419 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $2,420 | $616.22 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 239 | 335 | $101,410 | $22,727 | 22.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 93 | 93 | $78,643 | $20,134 | 25.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 117 | 117 | $77,954 | $12,683 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $47,907 | $10,778 | 22.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 154 | 157 | $72,063 | $10,068 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 99 | $42,759 | $10,049 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 116 | 116 | $42,984 | $9,500 | 22.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 42 | 42 | $25,746 | $8,299 | 32.2% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 21 | $15,836 | $3,383 | 21.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $11,770 | $2,876 | 24.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $8,289 | $2,668 | 32.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 18 | 18 | $9,144 | $2,228 | 24.4% |
About Dr. Patrick Hyatt, M.D
Dr. Patrick Hyatt, M.D is a Specialist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962432005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Hyatt, M.D has received a total of $5,908 in payments from pharmaceutical and medical device companies, with $639.77 received in 2024. These payments were reported across 306 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,908).
As a Medicare-enrolled provider, Hyatt has provided services to 4,044 Medicare beneficiaries, totaling 4,463 services with total Medicare billing of $460,459. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Baltimore, MD
- Active Since 07/04/2006
- Last Updated 02/18/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1962432005
Products in Payments
- CREON (Drug) $521.84
- XIFAXAN (Drug) $509.62
- STELARA (Biological) $493.10
- DUPIXENT (Biological) $330.42
- LINZESS (Drug) $312.34
- VIBERZI (Drug) $281.60
- DiLumen (Device) $231.48
- Creon (Drug) $228.34
- XELJANZ (Drug) $225.66
- HUMIRA (Biological) $225.21
- RINVOQ (Biological) $196.91
- Humira (Biological) $180.91
- ZENPEP (Drug) $170.60
- ENDOFLIP (Device) $144.45
- Amitiza (Drug) $141.18
- ZEPOSIA (Drug) $131.29
- MOTOFEN (Drug) $117.93
- MOTEGRITY (Drug) $108.43
- ENTYVIO (Biological) $107.66
- VOQUEZNA (Drug) $95.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Baltimore
Mr. James Gammie, M.d, M.D
Specialist — Payments: $29.8M
Specialist $29.8M
Dr. Richard Adler, M.d, M.D
Specialist — Payments: $3.1M
Specialist $3.1M
Dr. Philip Levin, M.d, M.D
Specialist — Payments: $921,481
Specialist $921,481
Dr. Agha Khan, Md, MD
Specialist — Payments: $170,581
Specialist $170,581
W. Eglseder, M.d, M.D
Specialist — Payments: $57,679
Specialist $57,679
Bartley Griffith, M.d, M.D
Specialist — Payments: $49,695
Specialist $49,695